| Literature DB >> 30100885 |
Nicole H Korman1,2, Shelukumar Shah1, Shuichi Suetani1,2, Karen Kendall3, Simon Rosenbaum4, Frances Dark1,2, Ketevan Nadareishvili1, Dan Siskind1,2.
Abstract
Purpose: People with severe mental illness are sedentary, have high cardio-metabolic risks and significantly reduced life expectancy. Despite considerable data regarding positive physical and mental health outcomes following exercise interventions, implementation and evaluation of real-world programs is lacking. The primary aim of this study was to assess the feasibility of an exercise intervention implemented by exercise physiology (EP) students within a residential rehabilitation unit for residents with severe mental illness, together with assessment of a range of secondary physical and mental health outcomes pre- and post- the intervention. Design: Single arm, prospective pilot study evaluating outcomes pre- and post- a 10 week intervention. Method: Inactive people with severe mental illness participated in a mixed aerobic and resistance exercise intervention, three times per week for 10 weeks. Data was obtained from a sample of 16 residents with severe mental illness; primary diagnosis schizophrenia (n = 12). Primary outcomes were feasibility as assessed using recruitment, retention and participation rates, as well as reasons for withdrawal and amount of exercise achieved. Secondary outcomes included: functional exercise capacity was measured by the 6-min walk test; metabolic data obtained from anthropometric measurements; blood pressure; fasting cholesterol and blood sugar levels; and physical activity levels and mental health as assessed by self- administered questionnaires measured before and after the intervention.Entities:
Keywords: mental health; exercise; exercise physiology; pilot study; rehabilitation; severe mental illness
Year: 2018 PMID: 30100885 PMCID: PMC6072846 DOI: 10.3389/fpsyt.2018.00343
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Baseline characteristics.
| Female; | 4 (30) | 3 (30) | 1 (33) |
| Male; | 9 (70) | 7 (70) | 2 (67) |
| Age (years), mean (SD) | 31 (7.9) | 32 (8) | 27.6 (8) |
| Duration of illness, years, mean (SD) | 10 (7.3) | 11.6 (7.3) | 5.1 (5.9) |
| Schizophrenia/schizoaffective | 12 (92) | 9 (90) | 3(100) |
| Bipolar affective disorder | 1 (8) | 1 (10) | 0 |
| Comorbid substance abuse | 4 (30) | 3 (30) | 1 (33) |
| Any antipsychotic | 12 (92) | 10 (100) | 2 (66) |
| Clozapine | 7 (54) | 7 (70) | 0 |
| Olanzapine | 4 (30) | 3 (30) | 1 (33) |
| Hypertension | 1(7) | 0 (0) | 0 (0) |
| Diabetes Mellitus | 0 (0) | 0 (0) | 0 (0) |
| Abnormal lipid profile | 4 (30) | 4(40) | 0 (0) |
| Current smoker | 7 (54) | 6 (60) | 1 (33) |
| Physical health problem identified on risk screen | 3 (23) | 3 (30) | 0 (0) |
Figure 1Enrollment and recruitment.
Pre- and post-measures.
| 6MWT distance | 452 (65) | 528 (85) | 76.8 (54, 99) | 7.78 (9) | <0.001 |
| npSelf reported exercise in previous week (minutes/week) | 60 (52.5) | 130 (15) | – | −2.346 | 0.019 |
| Self-reported sedentary behavior (hours/ day) | 7.9 (4.5) | 5.8 (2.5) | 2.1 (−0.5, 4.7) | −1.82 (9) | 0.101 |
| npFasting BSL | 5.1 (0.92) | 5.15 (0.72) | – | −0.95 | |
| Fasting total cholesterol (mmol/L) | 4.8 (0.57) | 4.6 (0.64) | 0.12 (−0.2, 0.44) | −0.83 (9) | |
| Body mass index (weight kg/height m2) | 29.2 (4.9) | 29.4 (4.6) | 0.19 (−0.12, −0.9) | 0.39 (9) | |
| Abdominal circumference (cm) | 100.9 (11.6) | 102.8 (12.7) | 1.85 (−6.7, 3.01) | 0.86 (9) | |
| Systolic blood pressure (mmHg) | 134.1 (19.7) | 127 (14.5) | 7 (−5.8, 19.8) | −1.23 (9) | 0.248 |
| Diastolic blood pressure (mmHg) | 85 (9.5) | 79.3 (8.6) | 5.7 (−0.7, 12) | −1.99 (9) | 0.078 |
| BPRS | 32.4 (8.3) | 29 (6.1) | 3.4 (0.03, 6.7) | −2.27 (9) | <0.049 |
| SANS | 45.2 (11.8) | 30.7 (12.7) | 14.5 (9.6, 6.8) | 6.8 (9) | <0.001 |
| BREQ-2 | |||||
| npAmotivation | 0.000 (0.81) | 0.000 (0.63) | – | −0.135 | |
| npExternal regulation | 1.12 (0.56) | 1.25 (1.13) | – | −0.949 | |
| Introjected regulation | 1.7 (1.25) | 1.6 (1.08) | 0.16 (−0.5, 0.84) | 0.56 (9) | |
| Identified regulation | 2.45 (1.16) | 2.85 (0.94) | 0.4 (−1.11, 0.31) | −1.2 (9) | 0.235 |
| Intrinsic regulation | 2.75 (0.87) | 2.5 (0.86) | 0.23 (0.06, 0.3) | 3.2 (9) | 0.01 |
| Autonomous regulation | 2.6 (0.8) | 2.68 (0.82) | 0.03 (−0.9, 0.83) | −0.097 (9) |
6MWT, 6 min walk distance;
BSL, Blood Sugar Level;
BPRS, Brief Psychiatric Rating Scale;
SANS, Scale for the Assessment of Negative Symptoms;
BREQ-2, Behavioral Exercise Regulations Questionnaire;
p < 0.05, significant;
np, nonparametric outcomes.
median (Interquartile range) for non-parametric outcomes.
z statistic for Wilcoxon signed rank test for nonparametric outcomes.